Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Chang

Showing results (241-250 of 386) with videos related to

Pageof 39
Sort By:
Neuro-Oncology|April 23, 2020
Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomasJulia Cluceru, Sarah J Nelson, Qiuting Wen, et al.
Neuro-Oncology|June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor ConsortiumSusan M Chang, Kathleen R Lamborn, John G Kuhn, et al.
Science (New York, N.Y.)|May 16, 2015
Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancerRobert J A Bell, H Tomas Rube, Alex Kreig, et al.
BMJ Global Health|December 6, 2019
The D-score: a metric for interpreting the early development of infants and toddlers across global settingsAnn M Weber, Marta Rubio-Codina, Susan P Walker, et al.
Neuro-Oncology|February 27, 2023
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adultsMichael Weller, Emilie Le Rhun, Martin Van den Bent, et al.
BMJ Open|April 29, 2024
SUPRAMAX-study: supramaximal resection versus maximal resection for glioblastoma patients: study protocol for an international multicentre prospective cohort study (ENCRAM 2201)Jasper Kees Wim Gerritsen, Jacob S Young, Susan M Chang, et al.
Sensors (Basel, Switzerland)|May 13, 2026
Development and First-in-Human Translation of Hyperpolarized [1-<sup>13</sup>C]Alpha-Ketoglutarate MR Spectroscopy in the BrainYaewon Kim, Duy Dang, James Slater, et al.
Neuro-Oncology|May 23, 2018
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working GroupNils D Arvold, Terri S Armstrong, Katherine E Warren, et al.
Journal of Neuro-Oncology|October 24, 2015
Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experienceBrandon S Imber, Steve E Braunstein, Fred Y Wu, et al.
Neuroimage. Clinical|July 6, 2020
Characterization of serial hyperpolarized <sup>13</sup>C metabolic imaging in patients with gliomaAdam W Autry, Jeremy W Gordon, Hsin-Yu Chen, et al.
Pageof 39

Showing results (241-250 of 386) with videos related to

Sort By:
Pageof 39
Neuro-Oncology|April 23, 2020
Recurrent tumor and treatment-induced effects have different MR signatures in contrast enhancing and non-enhancing lesions of high-grade gliomasJulia Cluceru, Sarah J Nelson, Qiuting Wen, et al.
Neuro-Oncology|June 19, 2008
Neurooncology clinical trial design for targeted therapies: lessons learned from the North American Brain Tumor ConsortiumSusan M Chang, Kathleen R Lamborn, John G Kuhn, et al.
Science (New York, N.Y.)|May 16, 2015
Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancerRobert J A Bell, H Tomas Rube, Alex Kreig, et al.
BMJ Global Health|December 6, 2019
The D-score: a metric for interpreting the early development of infants and toddlers across global settingsAnn M Weber, Marta Rubio-Codina, Susan P Walker, et al.
Neuro-Oncology|February 27, 2023
Diagnosis and management of complications from the treatment of primary central nervous system tumors in adultsMichael Weller, Emilie Le Rhun, Martin Van den Bent, et al.
BMJ Open|April 29, 2024
SUPRAMAX-study: supramaximal resection versus maximal resection for glioblastoma patients: study protocol for an international multicentre prospective cohort study (ENCRAM 2201)Jasper Kees Wim Gerritsen, Jacob S Young, Susan M Chang, et al.
Sensors (Basel, Switzerland)|May 13, 2026
Development and First-in-Human Translation of Hyperpolarized [1-<sup>13</sup>C]Alpha-Ketoglutarate MR Spectroscopy in the BrainYaewon Kim, Duy Dang, James Slater, et al.
Neuro-Oncology|May 23, 2018
Corticosteroid use endpoints in neuro-oncology: Response Assessment in Neuro-Oncology Working GroupNils D Arvold, Terri S Armstrong, Katherine E Warren, et al.
Journal of Neuro-Oncology|October 24, 2015
Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experienceBrandon S Imber, Steve E Braunstein, Fred Y Wu, et al.
Neuroimage. Clinical|July 6, 2020
Characterization of serial hyperpolarized <sup>13</sup>C metabolic imaging in patients with gliomaAdam W Autry, Jeremy W Gordon, Hsin-Yu Chen, et al.
Pageof 39